{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/53496"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/53496","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Method optimization foriIdentification and quantitation of mitragynine in commercial beverage products via GC-MS","abstract":"As of April 2026, 48 states have pending legislation on the regulation of kratom. Several states have taken the initiative to ban kratom and kratom-related products. This has come to include Feel Free® and Happy Hippo products, which contain both kratom and kava. Prior to 2026, kratom/kava products were available in gas stations, wellness stores, and smoke shops across the country, easily acquired with a single transaction. The availability of kratom has led to a significant increase in exposure, addiction, and overdose on these substances, spanning almost every age demographic from pre-teens to the elderly. The addictiveness of these products is highlighted by mitragynine, the main alkaloid of kratom, and its higher binding affinity to the mu receptor than morphine. As mitragynine is metabolized, the compound is converted into 7-hydroxymitragynine, a naturally present alkaloid found at low levels within kratom, which is even more potent than mitragynine. This increased potency of 7-hydroxymitragynine is often exploited by users and abused on its own in other commercial products. It was important for this research to optimize a GC-MS method for the detection and quantitation of mitragynine in Feel Free® and Happy Hippo products. Through the optimization of the Yulikawanti et al. method, a GC-MS method was developed. The quantitation of the original bottles of Feel Free® and Happy Hippo were calculated to be 34.573 mg and 78.942 mg, respectively, compared to the supplement labels' reported 40 mg and 50 mg.","abstract_html":"As of April 2026, 48 states have pending legislation on the regulation of kratom. Several states have taken the initiative to ban kratom and kratom-related products. This has come to include Feel Free® and Happy Hippo products, which contain both kratom and kava. Prior to 2026, kratom/kava products were available in gas stations, wellness stores, and smoke shops across the country, easily acquired with a single transaction. The availability of kratom has led to a significant increase in exposure, addiction, and overdose on these substances, spanning almost every age demographic from pre-teens to the elderly. The addictiveness of these products is highlighted by mitragynine, the main alkaloid of kratom, and its higher binding affinity to the mu receptor than morphine. As mitragynine is metabolized, the compound is converted into 7-hydroxymitragynine, a naturally present alkaloid found at low levels within kratom, which is even more potent than mitragynine. This increased potency of 7-hydroxymitragynine is often exploited by users and abused on its own in other commercial products. It was important for this research to optimize a GC-MS method for the detection and quantitation of mitragynine in Feel Free® and Happy Hippo products. Through the optimization of the Yulikawanti et al. method, a GC-MS method was developed. The quantitation of the original bottles of Feel Free® and Happy Hippo were calculated to be 34.573 mg and 78.942 mg, respectively, compared to the supplement labels&#x27; reported 40 mg and 50 mg.","abstract_has_math":false,"creators":["Leming, Mari Margaret"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Biomedical Forensic Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Hall, Adam B."],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T20:18:47Z","subjects":["Forensic sciences","Chemistry","Commercial Beverage Products","Gas chromatography","Kava","Kratom","Mass spectrometry","Mitragynine"],"languages":["en_US"],"rights":["Attribution 4.0 International"],"rights_urls":["http://creativecommons.org/licenses/by/4.0/"],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/53496","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/53496","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F53496","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Hall, Adam B."]},{"key":"dc:creator","label":"Author","values":["Leming, Mari Margaret"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-09-18T15:28:32Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2026-09-18T15:28:32Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2026-09-16T16:15:29Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical Forensic Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Forensic sciences","Chemistry","Commercial Beverage Products","Gas chromatography","Kava","Kratom","Mass spectrometry","Mitragynine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution 4.0 International"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://creativecommons.org/licenses/by/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/53496"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["2026"]},{"key":"dc:description.abstract","label":"Abstract","values":["As of April 2026, 48 states have pending legislation on the regulation of kratom. Several states have taken the initiative to ban kratom and kratom-related products. This has come to include Feel Free® and Happy Hippo products, which contain both kratom and kava. Prior to 2026, kratom/kava products were available in gas stations, wellness stores, and smoke shops across the country, easily acquired with a single transaction. The availability of kratom has led to a significant increase in exposure, addiction, and overdose on these substances, spanning almost every age demographic from pre-teens to the elderly. The addictiveness of these products is highlighted by mitragynine, the main alkaloid of kratom, and its higher binding affinity to the mu receptor than morphine. As mitragynine is metabolized, the compound is converted into 7-hydroxymitragynine, a naturally present alkaloid found at low levels within kratom, which is even more potent than mitragynine. This increased potency of 7-hydroxymitragynine is often exploited by users and abused on its own in other commercial products. It was important for this research to optimize a GC-MS method for the detection and quantitation of mitragynine in Feel Free® and Happy Hippo products. Through the optimization of the Yulikawanti et al. method, a GC-MS method was developed. The quantitation of the original bottles of Feel Free® and Happy Hippo were calculated to be 34.573 mg and 78.942 mg, respectively, compared to the supplement labels' reported 40 mg and 50 mg."]},{"key":"dc:title","label":"Title","values":["Method optimization foriIdentification and quantitation of mitragynine in commercial beverage products via GC-MS"]}]}],"canonical_facts":{"dc:contributor.advisor":["Hall, Adam B."],"dc:creator":["Leming, Mari Margaret"],"dc:date.accessioned":["2026-09-18T15:28:32Z"],"dc:date.available":["2026-09-18T15:28:32Z"],"dc:date.issued":["2026"],"dc:date.updated":["2026-09-16T16:15:29Z"],"dc:description":["2026"],"dc:description.abstract":["As of April 2026, 48 states have pending legislation on the regulation of kratom. Several states have taken the initiative to ban kratom and kratom-related products. This has come to include Feel Free® and Happy Hippo products, which contain both kratom and kava. Prior to 2026, kratom/kava products were available in gas stations, wellness stores, and smoke shops across the country, easily acquired with a single transaction. The availability of kratom has led to a significant increase in exposure, addiction, and overdose on these substances, spanning almost every age demographic from pre-teens to the elderly. The addictiveness of these products is highlighted by mitragynine, the main alkaloid of kratom, and its higher binding affinity to the mu receptor than morphine. As mitragynine is metabolized, the compound is converted into 7-hydroxymitragynine, a naturally present alkaloid found at low levels within kratom, which is even more potent than mitragynine. This increased potency of 7-hydroxymitragynine is often exploited by users and abused on its own in other commercial products. It was important for this research to optimize a GC-MS method for the detection and quantitation of mitragynine in Feel Free® and Happy Hippo products. Through the optimization of the Yulikawanti et al. method, a GC-MS method was developed. The quantitation of the original bottles of Feel Free® and Happy Hippo were calculated to be 34.573 mg and 78.942 mg, respectively, compared to the supplement labels' reported 40 mg and 50 mg."],"dc:identifier.uri":["https://hdl.handle.net/2144/53496"],"dc:language.iso":["en_US"],"dc:rights":["Attribution 4.0 International"],"dc:rights.uri":["http://creativecommons.org/licenses/by/4.0/"],"dc:subject":["Forensic sciences","Chemistry","Commercial Beverage Products","Gas chromatography","Kava","Kratom","Mass spectrometry","Mitragynine"],"dc:title":["Method optimization foriIdentification and quantitation of mitragynine in commercial beverage products via GC-MS"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Biomedical Forensic Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T20:18:47Z"}